Anthony T. Reder to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Anthony T. Reder has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.176
-
Asymptomatic brainstem lesions and pachymeningeal enhancement after anti-PD-1 therapy. Immunotherapy. 2021 01; 13(1):11-17.
Score: 0.128
-
Ocrelizumab treatment for relapsing-remitting multiple sclerosis after a suboptimal response to previous disease-modifying therapy: A nonrandomized controlled trial. Mult Scler. 2022 04; 28(5):790-800.
Score: 0.034
-
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis. Neurology. 2008 Jul 08; 71(2):136-44.
Score: 0.014